ELV
CNMD
MCO

Mark Kaye

Known title: EVP & CFOCIK: 0001748691

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.

this person other insiders at ELV

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CNMD Featured in Low-Volatility Stock List. Conmed was included in a recent Yahoo Finance article highlighting three low-volatility stocks with questionable fundamentals. The piece suggests that while the stock may exhibit stable price movements, underlying financial metrics warrant closer scrutiny. This context is relevant for investors assessing the balance between the company's current valuation and its operational stability.

this person other insiders at CNMD

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Moody's faces credit risk shift as rates rise, analysts adjust outlook. Moody's upgraded Egypt to a B3 rating, citing recent fiscal reforms and a positive outlook. The chief credit officer said higher interest rates are prompting a reassessment of credit risk across its portfolio. Analysts at JP Morgan kept an overweight stance but lowered their price target, reflecting the impact of rising Treasury yields on Moody's exposure. These developments show the firm adapting to a tighter rate environment while continuing sovereign rating activity.

this person other insiders at MCO

Transaction History

ELV▼ Sell$1.6M
ELV▲ Buy$0
CNMD▲ Buy$0
ELV▼ Sell$100K
ELV▼ Sell$80K
ELV▲ Buy$0
ELV▲ Buy$0
CNMD▲ Buy$0
ELV▼ Sell$985K
ELV▼ Sell$1.9M
ELV▼ Sell$107K
ELV▲ Buy$0
ELV▼ Sell$1.4M
ELV▲ Buy$0
ELV▲ Buy$0
ELV▲ Buy$0
MCO▼ Sell$1.3M
MCO▲ Buy$302K
MCO▼ Sell$594K
MCO▲ Buy$973K
MCO▼ Sell$1.2M
MCO▲ Buy$198K
MCO▲ Buy$1.1M
MCO▼ Sell$1.3M
MCO▲ Buy$503K
MCO▼ Sell$526K
MCO▼ Sell$244K
MCO▼ Sell$15K
MCO▼ Sell$310K
MCO▼ Sell$996K
MCO▲ Buy$0
MCO▲ Buy$545K
MCO▲ Buy$302K
MCO▲ Buy$215K
MCO▼ Sell$443K
MCO▼ Sell$561K
MCO▼ Sell$12K
MCO▼ Sell$1.2M
MCO▼ Sell$1.4M
MCO▲ Buy$0
MCO▲ Buy$520K
MCO▼ Sell$126K
MCO▼ Sell$396K
MCO▲ Buy$486K
MCO▼ Sell$658K
MCO▲ Buy$99K
MCO▼ Sell$135K

We use analytics to understand how market-wall is used. No personal data is sold.